Eventide Healthcare & Life Sciences Fund (ETIHX)
The investment seeks to provide long-term capital appreciation. Under normal market conditions, the fund invests at least 80% of its net assets (plus borrowings for investment purposes) in equity and equity-related securities of companies in the healthcare and life sciences sectors, including common stock, options, preferred stock and convertible debt. It may invest without limitation in securities of companies domiciled outside the United States either directly or through American Depositary Receipts ("ADRs"). The fund may invest in securities of companies of any market capitalization.
Fund Info
US62827M7065
62827M706
Dec 26, 2012
$100,000
Small-Cap
Growth
Expense Ratio
ETIHX has a high expense ratio of 1.30%, indicating higher-than-average management fees.
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Eventide Healthcare & Life Sciences Fund, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Eventide Healthcare & Life Sciences Fund had a return of 3.76% year-to-date (YTD) and -8.61% in the last 12 months. Over the past 10 years, Eventide Healthcare & Life Sciences Fund had an annualized return of 4.84%, while the S&P 500 had an annualized return of 11.33%, indicating that Eventide Healthcare & Life Sciences Fund did not perform as well as the benchmark.
ETIHX
3.76%
-4.03%
-4.62%
-8.61%
-3.44%
4.84%
^GSPC (Benchmark)
0.62%
-1.93%
5.98%
23.72%
12.67%
11.33%
Monthly Returns
The table below presents the monthly returns of ETIHX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -2.57% | 7.76% | -0.23% | -12.35% | 0.59% | -0.26% | 8.51% | 0.84% | -2.20% | -1.15% | 1.94% | -9.52% | -10.13% |
| 2023 | 6.36% | -2.23% | -5.36% | 7.13% | 4.04% | 3.09% | 0.13% | -6.36% | -5.77% | -9.37% | 4.11% | 17.75% | 11.01% |
| 2022 | -18.54% | -3.76% | -2.06% | -15.82% | -3.66% | 4.92% | 7.93% | 9.64% | -3.80% | 1.88% | 1.18% | 4.84% | -19.62% |
| 2021 | -4.51% | 3.93% | -6.87% | -0.84% | -7.85% | 0.38% | -4.95% | 10.09% | -0.35% | 1.04% | -9.06% | -6.41% | -23.97% |
| 2020 | -5.18% | -6.98% | -13.43% | 16.57% | 15.58% | 2.16% | -6.27% | 7.44% | 1.60% | 8.59% | 12.31% | 1.00% | 32.47% |
| 2019 | 13.91% | 8.92% | 8.49% | -5.07% | -1.54% | 6.10% | -1.64% | -8.79% | -9.51% | 8.28% | 23.68% | 7.06% | 55.40% |
| 2018 | 8.33% | 0.99% | -4.23% | 2.70% | 9.54% | 2.14% | 0.77% | 8.12% | 0.66% | -14.11% | -0.58% | -17.41% | -6.88% |
| 2017 | 4.23% | 6.49% | 1.75% | -0.18% | -6.88% | 11.80% | 1.95% | 7.56% | 8.11% | -2.29% | 3.80% | 1.97% | 43.91% |
| 2016 | -26.97% | -4.63% | 9.53% | 4.38% | 5.35% | -6.32% | 7.76% | -1.73% | 11.84% | -12.88% | 9.27% | -5.23% | -16.03% |
| 2015 | 2.80% | 5.73% | 2.97% | -2.29% | 13.03% | 0.92% | 3.20% | -11.48% | -14.05% | 8.97% | 11.48% | -4.39% | 13.78% |
| 2014 | 11.98% | 5.27% | -7.61% | -11.73% | -1.09% | 13.50% | -10.13% | 7.35% | 0.53% | 7.81% | 4.35% | 9.81% | 29.30% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of ETIHX is 3, meaning it’s performing worse than 97% of other mutual funds on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Eventide Healthcare & Life Sciences Fund (ETIHX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Eventide Healthcare & Life Sciences Fund provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.
| Period | TTM | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Dividend | $0.00 | $0.00 | $0.00 | $0.00 | $0.74 |
Dividend yield | 0.00% | 0.00% | 0.00% | 0.00% | 1.78% |
Monthly Dividends
The table displays the monthly dividend distributions for Eventide Healthcare & Life Sciences Fund. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | |||||||||||
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.74 | $0.74 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Eventide Healthcare & Life Sciences Fund. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Eventide Healthcare & Life Sciences Fund was 58.95%, occurring on May 9, 2022. The portfolio has not yet recovered.
The current Eventide Healthcare & Life Sciences Fund drawdown is 40.30%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -58.95% | Feb 10, 2021 | 314 | May 9, 2022 | — | — | — |
| -44.6% | Jul 20, 2015 | 142 | Feb 9, 2016 | 415 | Oct 2, 2017 | 557 |
| -36.33% | Jan 21, 2020 | 41 | Mar 18, 2020 | 50 | May 29, 2020 | 91 |
| -36.01% | Oct 1, 2018 | 59 | Dec 24, 2018 | 232 | Nov 25, 2019 | 291 |
| -27.88% | Feb 28, 2014 | 49 | May 8, 2014 | 149 | Dec 9, 2014 | 198 |
Volatility
Volatility Chart
The current Eventide Healthcare & Life Sciences Fund volatility is 7.48%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.